Use of Multiple Sclerosis Drugs Among Live Birth Pregnancies in the United States

    Basic Details
    Date
    Tuesday, August 21, 2018
    Type
    Presentation
    Medical Product
    alemtuzumab
    daclizumab
    dalfampridine
    dimethyl fumarate
    fingolimod
    glatiramer acetate
    interferon beta-1A
    interferon beta-1B
    mitoxantrone
    natalizumab
    peginterferon beta-1a
    teriflunomide
    Presenter(s)

    Danijela Stojanovic, Mayura Shinde, Nicole Haug, Mohamed Mohamoud, Leyla Sahin, Genna Panucci, Rajani Rajbhandari, Lockwood Taylor